Trials / Completed
CompletedNCT02026830
The Microbiologic Profile of Diabetic Foot Infections in Turkey - TURK-DAY
The Microbiologic Profile of Diabetic Foot Infections in Turkey (TURK-DAY): Prospective Multicenter Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 447 (actual)
- Sponsor
- Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
To determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
Detailed description
Recent studies have demonstrated substantial variation in the etiology of DFIs (Diabetic Foot Infections) in different regions of the world . In contrast to Western countries, studies from Asia and Africa have demonstrated that aerobic gram-negative organisms, particularly Pseudomonas aeruginosa, are far more common . The majority of current guidelines for the management of DFIs have been prepared in Western countries . Based on the results of more recent studies from the Asian continent, however, empiric antibiotic therapy for DFIs may need to be directed at organisms with substantially different antibiotic susceptibility patterns than those recommended in current guidelines. Thus, suggested antibiotic regimens for DFIs should be optimized for local clinical practice. The aim of the current trial is to provide an up-to-date view of the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-04-01
- Completion
- 2014-07-01
- First posted
- 2014-01-03
- Last updated
- 2015-03-11
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02026830. Inclusion in this directory is not an endorsement.